{"id":"W4414984131","doi":"10.1016/s2352-3026(25)00254-6","title":"Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Celgene; AbbVie; Bristol-Myers Squibb","keywords":"Venetoclax; Myeloid leukaemia; Refractory (planetary science); Myelodysplastic syndromes; Myeloid leukemia; Myeloid; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009002601,0.0008467343,0.001414918,0.0001808214,0.0001589055,0.000829454,0.0005427633,0.0007235353,0.004576006],"category_scores_gemma":[0.0007065541,0.0002353633,0.001002034,0.0002213719,0.0004713233,0.0006490168,0.0002559991,0.002439919,0.0006950254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005493119,"about_ca_system_score_gemma":0.000492467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005142502,"about_ca_topic_score_gemma":0.002556692,"domain_scores_codex":[0.9997906,0.0001079499,0.000007096445,0.00003594864,0.00001392972,0.00004446938],"domain_scores_gemma":[0.9997554,0.00006554592,0.00004431215,0.00001728769,0.0000116005,0.0001058598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7662138,0.007067209,0.003838421,0.002653345,0.003399942,0.0002777546,0.0002206734,0.003984898,0.01027795,0.001337133,0.01207049,0.1886583],"study_design_scores_gemma":[0.9092398,0.07149802,0.007042696,0.0001711234,0.0009916674,0.0003551624,0.00009819314,0.001479521,0.001006537,0.0009440662,0.007139726,0.00003356425],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734621,0.01767641,0.0004769136,0.001263667,0.0006500229,0.000643169,0.0013613,0.0001493232,0.004317304],"genre_scores_gemma":[0.9806139,0.007619161,0.001192087,0.001700738,0.0003002032,0.0006603982,0.002150361,0.00002991738,0.005733162],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004576006,"threshold_uncertainty_score":0.01530826,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03281879553664856,"score_gpt":0.3313487312351916,"score_spread":0.298529935698543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}